Cargando…
Right Ventricular Clot in Transit in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia Successfully Treated with Thrombolytics
BACKGROUND: Right heart thrombus or clot in transit is a rare venous thromboembolism (VTE) with high mortality. COVID-19 infection has been associated with increased risk of such events. We present the case of a 63-year-old man with no traditional VTE risk factors who was diagnosed with a clot in tr...
Autores principales: | Alali, Yaman, Jackson, Ian, Anani, Abedel Rahman, Varghese, Marisa, Khan, Muhammad Ebrahim, Pilli, Suchitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259549/ https://www.ncbi.nlm.nih.gov/pubmed/35811832 http://dx.doi.org/10.1155/2022/3483605 |
Ejemplares similares
-
Chylopericardium due to Subclavian Vein Thrombosis in the Setting of Protein S Deficiency
por: Jackson, Ian, et al.
Publicado: (2021) -
Development of an in vitro model to study clot lysis activity of thrombolytic drugs
por: Prasad, Sweta, et al.
Publicado: (2006) -
Thromboinflammation in coronavirus disease 2019: The clot thickens
por: Iffah, Raayma, et al.
Publicado: (2021) -
MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023) -
Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report
por: Papamichalis, Panagiotis, et al.
Publicado: (2020)